Related Experiment Video
Updated: May 1, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Nucleolin promotes TGF-β signaling initiation via TGF-β receptor I in glioblastoma
Shunzeng Lv1,2, Jie Zhang1,3, Mingzhi Han2
1Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Abstract:
The transforming growth factor β (TGF-β) pathway plays a key role in oncogenesis of advanced cancers, involving the non-Smad and Smad pathways. Meanwhile, nucleolin on the cell surface has been also reported to affect activation of signaling pathways. However, the effect of cell surface nucleolin on TGF-β pathway in glioblastoma is not still understood. Here, using antibodies of nucleolin and TGF-β receptor I (TβR-I), we observed blocking of either nucleolin or TβR-I inhibited the phosphorylation of CrkL, Erk1/2, and Smad2. Using nucleolin siRNA, nucleolin knockdown was also identified to suppress the expression of p-CrkL, p-Erk1/2, and p-Smad2. Furthermore, immunoprecipitation revealed the interaction between cell surface nucleolin and TβR-I on the U87 cell membrane. In addition, U87 cell wound-healing, soft-agar and MTT assay also showed si-nucleolin could obviously impair wound closure (p < 0.001), colony formation (p < 0.001) and cell growth (p < 0.001). In conclusion, nucleolin promotes and regulates the TGF-β pathway by interacting with TβR-I and is required for initiation and activation of TGF-β signaling. Thus, nucleolin could be a key factor in glioblastoma pathogenesis and considered a therapeutic target, which may also mediate more signaling pathways.
Insights
Cell surface nucleolin interacts with TGF-β receptor I, promoting glioblastoma growth. Blocking nucleolin or TβR-I inhibits cancer cell signaling and proliferation, identifying nucleolin as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The transforming growth factor β (TGF-β) pathway is crucial in advanced cancer oncogenesis.
- Cell surface nucleolin's role in TGF-β pathway activation, particularly in glioblastoma, remains unclear.
Purpose of the Study:
- To investigate the effect of cell surface nucleolin on the TGF-β pathway in glioblastoma.
- To determine if nucleolin is a potential therapeutic target for glioblastoma.
Main Methods:
- Antibodies targeting nucleolin and TGF-β receptor I (TβR-I) were used to block pathways.
- Nucleolin siRNA was employed for gene knockdown studies.
- Immunoprecipitation was performed to confirm protein interactions.
- Cellular assays including wound-healing, soft-agar, and MTT were conducted.
Main Results:
- Blocking nucleolin or TβR-I inhibited phosphorylation of CrkL, Erk1/2, and Smad2.
- Nucleolin knockdown suppressed the expression of p-CrkL, p-Erk1/2, and p-Smad2.
- Direct interaction between cell surface nucleolin and TβR-I was observed on U87 cell membranes.
- Nucleolin knockdown significantly impaired U87 cell wound closure, colony formation, and overall growth.
Conclusions:
- Cell surface nucleolin promotes and regulates the TGF-β pathway by interacting with TβR-I.
- Nucleolin is essential for the initiation and activation of TGF-β signaling in glioblastoma.
- Nucleolin represents a potential therapeutic target for glioblastoma treatment.
Related Concept Videos
TGF - β Signaling Pathway
The Nucleolus
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Intracellular Signaling Affects Focal Adhesions
Some...

